NCT01710982View on ClinicalTrials.gov

Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Postoperative Ileus
Interventions
DRUG

TZP-101

OTHER

Placebo

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY

NCT01710982 - Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection | Biotech Hunter | Biotech Hunter